Autolus Therapeutics plc Financial Flexibility Index
Autolus Therapeutics plc financial flexibility index. Autolus Therapeutics plc (6A3A) has a Financial Flexibility Index of -0.06x as of June 2026. Free cash flow of €-24.16 Million (operating CF €-25.07 Million minus capex €913.00K) represents 0% of total liabilities (€418.39 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Autolus Therapeutics plc (2017–2025)
Financial flexibility index of Autolus Therapeutics plc from 2017 to 2025. Historical Financial Flexibility Index trend for Autolus Therapeutics plc across 9 annual periods. Explore 6A3A operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Autolus Therapeutics plc Financial Flexibility Index by Year (2017–2025)
Autolus Therapeutics plc financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for Autolus Therapeutics plc. For the full cash flow conversion analysis, see Autolus Therapeutics plc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | €-256.44 Million | €-283.57 Million | €410.94 Million | ▼ -29.4% |
| 2024 | -0.48x | €-171.45 Million | €-206.27 Million | €355.40 Million | ▲ +5.4% |
| 2023 | -0.51x | €-134.60 Million | €-145.59 Million | €263.91 Million | ▲ +3.7% |
| 2022 | -0.53x | €-101.47 Million | €-112.31 Million | €191.60 Million | ▲ +55.2% |
| 2021 | -1.18x | €-109.00 Million | €-117.86 Million | €92.24 Million | ▲ +3.5% |
| 2020 | -1.22x | €-103.08 Million | €-117.76 Million | €84.20 Million | ▲ +28.3% |
| 2019 | -1.71x | €-83.14 Million | €-101.48 Million | €48.69 Million | ▼ -1.8% |
| 2018 | -1.68x | €-29.75 Million | €-42.52 Million | €17.74 Million | ▲ +24.6% |
| 2017 | -2.22x | €-13.48 Million | €-16.36 Million | €6.06 Million | — |